The most practical way to compare prices is to put two numbers side by side: what a Japanese self-pay patient would pay for the same treatment, and what the provider is quoting you.
Start With the Japanese Self-Pay Price
Before looking at package names or “international patient” offers, get these two prices in writing:
- the standard self-pay price for a Japanese patient;
- the total price quoted to an overseas patient.
If there is a gap, the provider should be able to show where it comes from.
| Possible Difference | What to Ask |
|---|---|
| Treatment fee | Is the medical procedure itself priced differently? |
| Interpretation | Is medical interpretation included or charged separately? |
| Translation | Which medical records must be translated and how much does it cost? |
| International coordination | Is there a separate coordinator or overseas-patient service fee? |
| Payment | Are bank, card or foreign-currency fees added? |
This gives you a much clearer answer than simply asking whether the clinic has a “foreigner surcharge.”
Check the Hospital’s Price per Medical Fee Point
Japan’s insured medical fee calculation generally uses ¥10 per medical fee point.
10,000 points × ¥10 = ¥100,000
For certain medical organizations covered by a 2026 MHLW rule, a separate self-pay price may be set for visiting foreign patients who are not enrolled in Japanese public medical insurance. The permitted price is subject to applicable local limits and cannot exceed the equivalent of ¥30 per medical fee point.[1]
At ¥30 per point:
10,000 points × ¥30 = ¥300,000
If the hospital uses point-based pricing for your care, you need three clear answers:
- What rate per point will you use for me?
- Does that rate apply to the whole bill or only certain services?
- Which rule or internal pricing policy is being used?
¥30 per point is an upper limit under the applicable framework, not a mandatory price for every foreign patient and not a general pricing rule for every private stem cell clinic.
Hospital Data Is a Benchmark, Not a Stem Cell Price List
An MHLW survey of 5,864 hospitals shows how self-pay charges for foreign patients can vary. It covered general hospital care and was not a stem cell therapy price survey.[2]
| Charge per Medical Fee Point | Hospitals |
|---|---|
| ¥10 or less | 81.4% |
| More than ¥10 to ¥15 | 6.3% |
| More than ¥15 to ¥20 | 4.6% |
| More than ¥20 | 2.7% |
| Did not use the medical fee schedule | 5.0% |
Pricing looked different among 84 JMIP or JIH-accredited hospitals: 41.7% charged more than ¥20 per point and 29.8% charged ¥10 or less.[2]
Among 797 hospitals reporting rates above ¥10 per point, the reasons given were:
- 48.6% cited administrative procedures;
- 31.1% cited additional treatment time;
- 30.0% cited interpretation-related reasons;
- 28.7% cited measures related to unpaid medical bills.
These numbers are useful for understanding foreign-patient hospital pricing. They are not a shortcut for estimating the average cost of stem cell therapy.
Find Out Whether the Treatment Is Self-Pay
The insurance question comes before the package-price question:
- Is this exact treatment covered by Japanese public health insurance?
- If not, what is the standard self-pay price?
- Is the same self-pay price offered to Japanese patients?
A foreign resident enrolled in Japanese public health insurance is not automatically in the same billing situation as an uninsured medical tourist.
At the same time, many privately provided regenerative medicine treatments are self-pay. Japanese patients may therefore also have to pay the full treatment fee.
Do not mix up regulatory status and insurance coverage. A treatment being legally available, or a product being approved, does not automatically mean public insurance pays for it.
Make Sure You Are Comparing the Same Treatment
Two clinic prices mean very little unless the treatment details match.
| Item | What Must Match |
|---|---|
| Cell source | Adipose tissue, bone marrow, blood or another source |
| Cell ownership | Patient’s own cells or donor-derived cells |
| Collection | Whether tissue or cell collection is included |
| Processing | Culture, expansion, testing and preparation |
| Cell dose | Planned dose and how it is measured |
| Administration | Intravenous, joint injection, local injection or another route |
| Sessions | Price per treatment or price for a complete course |
| Storage | Whether storage and later preparation are included |
| Testing | Blood tests, infection screening and imaging |
| Follow-up | Number and location of follow-up visits |
A ¥2 million price for one administration cannot be compared directly with a ¥4 million package containing three administrations.
Cell numbers need the same caution. A treatment advertised as “200 million cells” is not automatically twice as effective as one using 100 million cells. What matters is the cell type, viability, administration route and the reason that dose was chosen.
The usual stages are covered in the stem cell treatment process in Japan.
See What Cell Collection and Processing Actually Include
Autologous treatment starts with cells or tissue being collected from the patient. That part of the process can carry its own costs, so the quote should show whether these items are included:
- doctor’s collection fee;
- local anesthesia or other anesthesia;
- procedure-room costs;
- sterile equipment;
- cell isolation;
- cell culture and expansion;
- quality testing;
- storage;
- preparation before administration.
There should also be a clear answer for what happens if the first collection does not produce enough usable cells. A second collection or another processing attempt may create a large additional cost.
More information about processing is available in the cell processing center guide.
Separate International-Patient Fees From the Medical Fee
International packages are easier to compare when each service is priced separately:
- medical-record review;
- remote consultation;
- in-person consultation;
- document translation;
- medical interpretation;
- appointment coordination;
- international patient support;
- visa-related medical documents when required;
- bank-transfer fees;
- credit-card fees;
- currency-conversion costs.
In the MHLW hospital survey, 12.6% of the 5,864 hospitals reported additional charges outside the normal medical fee schedule for foreign self-pay patients. Among the 740 hospitals reporting such charges, 23.5% reported document-translation fees and 14.9% reported interpreter fees.[2]
If the medical fee and international-patient service fee are bundled together, ask for an itemized written quote before paying.
Count the Trips Before You Judge the Price
A lower treatment fee can quickly lose its advantage if the protocol requires several trips to Japan.
The treatment calendar should show:
- How many days are needed for the first assessment?
- Is cell collection performed during the same trip?
- How long is the processing period?
- When is the treatment administered?
- Are repeat administrations required?
- Which follow-up visits must be completed in Japan?
- Which follow-up visits can be completed remotely?
A clinic with a lower treatment fee can still cost more overall if it requires several additional trips to Japan.
Read the ¥2.2 Million Public Record in Context
One treatment document available through Japan’s public regenerative medicine database lists a self-pay price of ¥2,200,000 including tax per treatment for a specific autologous adipose-derived mesenchymal stem cell treatment plan.[3]
| Item | Public Record |
|---|---|
| Treatment | ¥2,200,000 including tax per treatment |
| Public insurance | Not covered |
| Price variation | May vary according to the patient’s condition and circumstances |
| Cancellation after costs arise | Costs already incurred may remain payable |
| Follow-up | Approximately every 30 days until six months after treatment |
Do not use ¥2.2 million as the average Japanese stem cell therapy price. It is one provider’s treatment plan for a specific treatment.
What this record does show is the level of detail worth looking for: treatment price, insurance status, cancellation terms and follow-up requirements.
Read the Deposit and Cancellation Terms Before Paying
The deposit terms matter because costs can start before the treatment itself is administered.
- How much is the deposit?
- When does it become non-refundable?
- What happens if tissue collection fails?
- What happens if enough usable cells cannot be produced?
- Is another processing attempt included?
- Does another tissue collection cost extra?
- What happens if the doctor decides not to proceed?
- What happens if the patient cancels?
Processing failure and treatment failure are not the same thing:
- Processing failure: suitable cells cannot be prepared for administration.
- Treatment failure: the treatment is administered but does not produce meaningful clinical improvement.
The financial terms for these situations can be completely different.
Check the Payment Currency and Fees
Small percentages become meaningful when the medical bill is large.
2% of ¥4,000,000 = ¥80,000.
Before transferring money, confirm:
- whether the bill is fixed in Japanese yen;
- which exchange rate is used;
- whether the sender pays transfer fees;
- whether the receiving bank charges a fee;
- whether credit-card fees are added;
- whether the quoted price includes Japanese consumption tax.
Do Not Accept “Approved in Japan” Without Details
If a provider uses the phrase “approved in Japan,” the useful information is the exact record behind that claim:
- the exact product or treatment name;
- the law or regulatory framework being referred to;
- the exact disease or indication;
- the relevant public record.
Japan has marketing approval for named regenerative medical products under the Pharmaceuticals and Medical Devices Act. PMDA publishes approved regenerative medical products.[4]
Japan also has a separate system for regenerative medicine provided by medical institutions under the Act on the Safety of Regenerative Medicine. Providers must follow the applicable review and submission procedures for regenerative medicine provision plans.[5]
A regenerative medicine provision plan is not the same as marketing approval of a named regenerative medical product.
For a more detailed explanation, see the Japan regenerative medicine registration and compliance guide.
Make Success-Rate Claims Show Their Work
A number such as “80% improved” or “90% success rate” is only useful when the provider can show what sits behind it:
- number of patients;
- exact diagnosis;
- cell type;
- administration route;
- definition of “success” or “improvement”;
- length of follow-up.
Without those details, the percentage should not be used to estimate your own chance of improvement.
The research also needs to match the treatment being sold. Evidence from another disease, another cell type or another administration route should not be treated as evidence for your treatment.
Put Two Quotes Side by Side
| Cost or Treatment Item | Clinic A | Clinic B |
|---|---|---|
| Standard Japanese self-pay price | ||
| International-patient price | ||
| Exact treatment | ||
| Cell source | ||
| Patient’s own or donor cells | ||
| Cell collection | ||
| Cell processing | ||
| Quality testing | ||
| Cell dose | ||
| Administration route | ||
| Number of sessions | ||
| Tests and imaging | ||
| Cell storage | ||
| Medical interpretation | ||
| Document translation | ||
| International coordination | ||
| Follow-up | ||
| Number of trips to Japan | ||
| Tax | ||
| Deposit | ||
| Cancellation terms | ||
| Processing-failure policy | ||
| Total medical cost |
The headline price is only useful when both providers are offering the same treatment, the same number of sessions and the same included services.
Get These Items in Writing Before You Pay
- exact treatment name;
- condition being treated;
- cell source;
- patient’s own or donor-derived cells;
- collection method;
- processing facility and method;
- planned cell dose;
- administration route;
- number of sessions;
- tests and imaging included;
- standard self-pay treatment price;
- international-patient charges;
- translation and interpretation fees;
- coordination fees;
- tax;
- payment currency;
- bank or card fees;
- deposit amount;
- cancellation terms;
- policy if cell processing fails;
- storage fees;
- number of trips required;
- follow-up schedule;
- plan and cost responsibility if complications occur.
Treat These Claims as Incomplete Until Details Are Provided
| Claim | Required Details |
|---|---|
| “Government approved” | Exact product or treatment, regulatory system and indication |
| “200 million premium stem cells” | Cell identity, viability, processing method and dose rationale |
| “90% success rate” | Patient number, success definition and follow-up period |
| “No side effects” | Collection, processing and administration risks |
| “Treats many diseases” | Clinical evidence for the patient’s exact diagnosis |
| “Special foreign patient price” | Itemized difference from the standard Japanese self-pay price |
Immediate payment pressure, no itemized quotation, an unclear cell source, vague regulatory claims, or missing written cancellation and complication policies are all reasons to stop and get more information before paying.
Finally
Do not judge the cost of stem cell therapy in Japan from one advertised package price. Start with the Japanese self-pay price for the same treatment, then add any international-patient fees and travel costs. MHLW’s 5,864-hospital survey found that 81.4% charged ¥10 or less per medical fee point, while 41.7% of 84 JMIP/JIH hospitals charged more than ¥20. The 2026 framework permits certain specified organizations to charge up to ¥30 per point within applicable limits, but this is not a nationwide three-times price for foreigners. For private stem cell treatment, compare cell source, processing, dose, sessions, follow-up, cancellation terms and the final written total before paying.
Sources
- Ministry of Health, Labour and Welfare: Self-pay medical fee limits for visiting foreign patients at specified medical organizations
- Ministry of Health, Labour and Welfare: Survey on medical institutions accepting foreign patients
- MHLW Regenerative Medicine Public Database: Treatment explanation and consent document
- PMDA: Approved Regenerative Medical Products
- Ministry of Health, Labour and Welfare: Regenerative Medicine Provision Plan Procedures
Medical disclaimer: This article is for general educational purposes only and is not medical advice, diagnosis or a recommendation to undergo stem cell or regenerative medicine treatment. Treatment evidence, prices, insurance coverage and regulatory status can change. Confirm current treatment details, written costs and regulatory information with the relevant medical institution and qualified medical professionals before making medical or financial decisions.